People with gender dysphoria who self-prescribe cross-sex hormones: Prevalence, sources, and side effects knowledge

Journal of Sexual Medicine

Volumn 11, Issue 12, 2014, Pages 2995-3001

  Mepham, Nick ^a   Bouman, Walter P ^a   Arcelus, Jon ^b   Hayter, Mark ^c   Wylie, Kevan R ^d  

^a Mandala Centre   (United Kingdom)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

^d Nether Edge Hospital   (United Kingdom)

Author keywords

Cross sex hormones; Gender dysphoria; Internet; Prevalence; Transgender; Transsexualism

Indexed keywords

ESTROGEN; TESTOSTERONE; NON PRESCRIPTION DRUG; SEX HORMONE;

ADULT; ARTICLE; AWARENESS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FEMALE TO MALE TRANSGENDER; FRIEND; GENDER DYSPHORIA; GENERAL PRACTITIONER; HUMAN; INTERNET; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MALE TO FEMALE TRANSGENDER; PATIENT REFERRAL; PHYSICIAN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF PRESCRIBE; ADOLESCENT; AGED; ATTITUDE TO HEALTH; GENDER IDENTITY; MIDDLE AGED; SELF MEDICATION; SEX DIFFERENCE; SUPPLY AND DISTRIBUTION; TRANSSEXUALISM; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GENDER IDENTITY; GONADAL STEROID HORMONES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNET; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; QUESTIONNAIRES; SELF MEDICATION; SEX FACTORS; TESTOSTERONE; TRANSSEXUALISM; YOUNG ADULT;

EID: 84913609466     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12691     Document Type: Article

References (34)

1. Bouman WP. The good practice guidelines for the assessment and treatment of adults with gender dysphoria in the United Kingdom. Sex Relatsh Ther 2014;29:1-3.
2. Bouman WP, Richards C. Diagnostic and treatment issues for people with gender dysphoria in the United Kingdom. Sex Relatsh Ther 2013;28:165-171.
3. Davies A, Bouman WP, Richards C, Barrett J, Ahmad A, Baker K, Lenihan P, Lorimer S, Mepham N, Murjan S, Robbins-Cherry S, Seal L, Stradins L. Patient satisfaction with gender identity clinic services in the United Kingdom. Sex Relatsh Ther 2013;28:400-418.
4. Ahmad S, Barrett J, Beaini A, Bouman WP, Davies A, Greener HM, Lenihan P, Lorimer S, Murjan S, Richards C, Seal LJ, Stradins L. Gender dysphoria services: A guide for general practitioners and other healthcare staff. Sex Relatsh Ther 2013;28:173-186.
5. Cohen-Kettenis PT, Gooren LJ, Gijs L, Ritt M, Boenink AD. Concerns relating to care for transsexuals. Ned Tijdschr Geneeskd 2004;148:2140-2141.
6. Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer WJ, Monstrey S, Adler RK, Brown GR, Devor AH, Ehrbar R, Ettner R, Eyler E, Garofalo R, Karasic DH, Lev AI, Mayer G, Meyer-Bahlburg H, Hall BP, Pfaefflin F, Rachlin K, Robinson B, Schechter LS, Tangpricha V, van Trotsenburg M, Vitale A, Winter S, Whittle S, Wylie KR, Zucker K. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism 2012;13:165-232.
7. Wylie KR, Barrett J, Besser M, Bouman WP, Bridgeman M, Clayton A, Green R, Hamilton M, Hines M, Ivbijaro G, Khoosal D, Lawrence A, Lenihan P, Lowenthal D, Ralph D, Reed T, Stevens J, Terry T, Thom B, Thornton J, Walsh D, Ward D. Good practice guidelines for the assessment and treatment of adults with gender dysphoria. Sex Relatsh Ther 2014;29:154-214.
8. Crawford S. Internet pharmacy: Issues of access, quality, costs, and regulation. J Med Syst 2003;27:57-65.
9. Bessell TL, Anderson JN, Silagy CA, Sansom LN, Hiller JE. Surfing, self-medicating and safety: Buying non-prescription and complementary medicines via the internet. Qual Saf Health Care 2003;12:88-92.
10. Weiss AM. Buying prescription drugs on the internet: Promises and pitfalls. Cleve Clin J Med 2006;73:282-288.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000.
12. World Health Organization. International Classification of Diseases 10. 2nd edition. Geneva: World Health Organization; 1992.
13. Horne R, Weinman J, Hankins M. The Beliefs About Medicines Questionnaire. The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14:1-24.
14. Tanner SM, Miller DW, Alongi C. Anabolic steroid use by adolescents: Prevalence, motives and knowledge of risks. Clin J Sport Med 1995;5:108-115.
15. IBM. IBM SPSS Statistic 19 [software program]. Armonk, NY: IBM; 1992.
16. Fay M, Proschan M. Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat Surv 2010;4:1-39.
17. Leinung MC, Urizare MF, Patel N, Sood SC. Endocrine treatment of transsexual persons: Extensive personal experience. Endocr Pract 2013;19:644-650.
18. Guadamuz TE, Wimonsate W, Varangrat A, Phanuphak P, Jommaroeng R, McNicholl JM, Mock PA, Tappero JW, van Griensven F. HIV prevalence, risk behaviour, hormone use and surgical history among transgender persons in Thailand. AIDS Behav 2011;15:650-658.
19. Sánchez NF, Sánchez JP, Danoff A. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York city. Am J Public Health 2009;99:713-719.
20. Ashbee O, Goldberg JM. Hormones: a guide for FTMs. Vancouver, BC: Vancouver Coastal Health; 2006. Available at: http://www.camh.ca/en/hospital/care_program_and_services/hospital_services/Documents/hormones-FTM.pdf (accessed September 2, 2014).
21. Hudson's FTM Resource Guide. Hudson's FTM Resource Guide. Available at: http://www.ftmguide.org/ (accessed September 2, 2014).
22. Transgender Zone. Transgender hormone replacement therapy. Available at: http://www.transgenderzone.com/research/hrt.htm (accessed September 2, 2014).
23. Toorians AW, Thomassen MC, Zweegman S, Magdeleyns EJP, Tans G, Gooren LJ, Rosing J. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 2003;88:5723-5729.
24. Asscheman H, Giltay E, Megens J, De Ronder P, van Trotsenburg M, Gooren L. A long term follow up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 2011;164:635-642.
25. Kreukels BP, Haraldsen IR, DeCuypere G, Richter-Appelt H, Gijs L, Cohen-Kettenis PT. A European network for the investigation of gender incongruence: The ENIGI initiative. Eur Psychiatry 2012;27:445-450.
26. Nieder TO, Herff M, Cerwenka S, Preuss WF, Cohen-Kettenis PT, De Cuypere G, Hebold Haraldsen IR, Richter-Appelt H. Age of onset and sexual orientation in transsexual males and females. J Sex Med 2011;8:783-791.
27. National Health Service Audit, Information & Analysis Unit. Survey of patient satisfaction with transgender services. London: Department of Health; 2008.
28. McNeil J, Bailey L, Ellis S, Morton J, Regan M. Trans Mental Health and Emotional Wellbeing Study. Edinburgh: Scottish Transgender Alliance; 2012.
29. Fittler A, Bösze G, Botz L. Evaluating aspects of online medication safety in long-term follow-up of 136 Internet pharmacies: Illegal rogue pharmacies flourish and are long-lived. J Med Internet Res 2013;15:e199. doi: 10.2196/jmir.2606.
30. Hembree WC, Cohen-Kettenis PT, Delamarre-van de Waal H, Gooren LJ, Meyer WJ III, Spack N, Tangpricha V, Montori V. Endocrine treatment of transsexual persons: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009;94:3132-3154.
31. Mueller A, Zollver H, Kronawitter D, Oppelt PG, Claassen T, Hoffmann I, Beckmann MW, Dittrich R. Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Exp Clin Endocrinol Diabetes 2011;119:95-100.
32. Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, T'Sjoen G. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 2012;9:2641-2651.
33. T'Sjoen G, Van Caenegem E, Wierckx K. Transgenderism and reproduction. Curr Opin Endocrinol Diabetes Obes 2013;20:575-579.
34. General Medical Council. Good medical practice. London: General Medical Council; 2013.